About ICON

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,100 employees. Further information is available at www.iconplc.com.


Site and Patient Solutions Site and Patient Solutions

ICON's proven site and patient recruitment paradigm bridges the gap between patients and clinical research sites.

Commercialization And Outcomes Commercialization And Outcomes

ICON Commercialization & Outcomes (ICO) optimizes the value of drugs and medical devices through innovative strategies and tactics that reflect evolving evidentiary, regulatory, and reimbursement requirements.

Medical Writing and Publishing Medical Writing and Publishing

Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.


Flex Advantage offers enhanced randomization, clinical supply management capabilities and enables the execution of adaptive clinical trials.